bf/NASDAQ:AXGN_icon.jpeg

NASDAQ:AXGN

AxoGen, Inc.

  • Stock

USD

Last Close

7.77

28/03 20:00

Market Cap

410.21M

Beta: 0.62

Volume Today

161.45K

Avg: 228.48K

PE Ratio

−18.28

PFCF: −17.18

  • industry

    Medical Devices
  • exchange

    NASDAQ Capital Market
  • website

    www.axogeninc.com
  • ipo date

    Dec 17, 1986
  • full time employees

    394
  • currency

    USD

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without th...Show More

Earnings

Earnings per Share (Estimate*)

-0.25-0.2-0.15-0.1-0.052015-05-052017-05-042019-05-082021-05-052023-05-09

Revenue (Estimate*)

50M100M150M200M250M2015-05-052017-05-042019-05-082021-05-052023-05-09

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.